HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Correlations between the activities of 19 standard anticancer agents, antioxidative enzyme activities and the expression of ATP-binding cassette transporters: comparison with the National Cancer Institute data.

Abstract
The aim of this work was to determine the functional activities of four different antioxidative enzymes (glutathione reductase, glutathione-S-transferase, glutathione peroxidase, thioredoxin reductase) and the protein expression of three ATP-binding cassette transporters (P-glycoprotein, multidrug resistance protein 1, multidrug resistance protein 2) in a panel of 14 human cancer cell lines. Enzyme activities and transporter expression were then correlated with the in-vitro cytotoxic activities (GI50 values) of 19 standard antitumor drugs. Analogous data from the National Cancer Institute were used for comparison. The GI50 values of the platinum complexes, alkylating agents, antimetabolites, topoisomerase inhibitors and antimitotic drugs were determined by crystal violet or 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide assay. Standard enzymatic assays employed to measure the glutathione peroxidase, glutathione-S-transferase, glutathione reductase and thioredoxin reductase activities. The protein expression of the ATP-binding cassette transporter proteins was investigated by the Western-blot method. The delta method was used to normalize the data before bivariant correlation analysis. Only a few correlations between enzyme and cytotoxic activities of the antitumor agents were found. The GI50 values for melphalan and camptothecin correlated positively with the activity of glutathione-S-transferase, whereas GI50 values for methotrexate correlated positively with the cellular activities of both glutathione reductase and thioredoxin reductase. A significant correlation between glutathione reductase and thioredoxin reductase activities was found in our panel of cell lines. Neither P-glycoprotein nor multidrug resistance protein 2 expression could be detected by Western blot analysis in any cell lines investigated, but multidrug resistance protein 1 was consistently observed in all but four lines. Multidrug resistance protein 1 expression correlates positively with the GI50 values of several drugs, e.g. vinblastine and etoposide, and negatively with the GI50 values of 5-fluorouracil. The results confirm the complexity of resistance to antitumor agents and show that the GSH-thioredoxin system alone is not a good indication of intrinsic resistance for many of these anticancer drugs.
AuthorsKarin Bracht, Manuel Liebeke, Christoph A Ritter, Renate Grünert, Patrick J Bednarski
JournalAnti-cancer drugs (Anticancer Drugs) Vol. 18 Issue 4 Pg. 389-404 (Apr 2007) ISSN: 0959-4973 [Print] England
PMID17351391 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • ATP-Binding Cassette Transporters
  • Antineoplastic Agents
  • Antioxidants
  • Membrane Transport Proteins
  • Multidrug Resistance-Associated Protein 2
  • Multidrug Resistance-Associated Proteins
  • Glutathione Peroxidase
  • Glutathione Reductase
  • Thioredoxin-Disulfide Reductase
  • Glutathione Transferase
  • Glutathione
  • multidrug resistance-associated protein 1
Topics
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 (biosynthesis)
  • ATP-Binding Cassette Transporters (metabolism)
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Antioxidants (metabolism)
  • Blotting, Western
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Databases, Factual
  • Glutathione (metabolism)
  • Glutathione Peroxidase (metabolism)
  • Glutathione Reductase (metabolism)
  • Glutathione Transferase (metabolism)
  • Humans
  • Membrane Transport Proteins (metabolism)
  • Multidrug Resistance-Associated Protein 2
  • Multidrug Resistance-Associated Proteins (metabolism)
  • Thioredoxin-Disulfide Reductase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: